Literature DB >> 1463868

Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer.

H R Rosen1, C Moroz, A Reiner, M Reinerova, M Stierer, J Svec, M Schemper, R Jakesz.   

Abstract

Placental isoferritin (PLF), an acidic isoform of ferritin, and its unique superheavy chain p43 have been recently described to be synthesized by breast cancer cell lines but not by normal breast epithelial cells. Since previous reports have demonstrated a correlation between the content of 'normal' ferritin in breast cancer tissue, degree of differentiation, and prognosis, we have tried to evaluate the correlation of p43 in the cytosol of 122 breast cancer samples with commonly applied prognostic factors and features of proliferation and differentiation. In parallel, we investigated the correlation of p43 expression in MCF-7 and T47-D breast cancer cell lines during proliferation induced by estradiol plus fetal calf serum (assessed by 3H-thymidine incorporation), compared to p43 expression in stationary non-stimulated cell cultures. The levels of p43 in breast cancer cytosols correlated significantly negatively with tumor size (p = 0.0001), histologic grading (p = 0.0038), nuclear pleomorphism (p = 0.0019), rate of mitosis (p = 0.0002), and lymphocytic reaction (p = 0.0001), and significantly directly with the estrogen receptor status (p = 0.0009). Although patients with a higher p43 content showed a trend for a better outcome (median follow-up: 61.4 months), an independent influence of the cytosolic p43 content on survival could not be confirmed by a multivariate Cox model. In accordance with the observed negative correlation of features of differentiation vs. p43 expression, induction of proliferation by estradiol plus FCS added to serum-free tissue culture medium correlated with a decrease of p43 synthesis in both cell lines. Expression of p43 in estrogen and FCS-absent media revealed also a decrease in relation to a low spontaneous proliferation. However, the drop of p43 synthesis was significantly stronger in cell lines with estrogen-stimulated proliferation. Our in vitro and cytosol results confirm recent clinical observations describing an inverse correlation of p43 synthesis with the degree of proliferation and differentiation in breast cancer. However, the pathologic mechanisms leading to this phenomenon as well as the negative correlation with lymphocytic infiltration are still unclear and need to be further elucidated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463868     DOI: 10.1007/bf01832354

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

1.  Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer.

Authors:  M Stierer; H Rosen; R Weber
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

2.  Carcinofetal human isoferritins.

Authors:  J W Drysdale; E Alpert
Journal:  Ann N Y Acad Sci       Date:  1975-08-22       Impact factor: 5.691

3.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer.

Authors:  R Bilik; C Mor; B Hazaz; C Moroz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  The use of oncofetal ferritin-bearing lymphocytes as a marker for the screening, diagnosis, and follow-up of patients with early breast malignancy screening of 3400 women.

Authors:  C Moroz; M Kahn; E Ron; H Luria; C Chaimoff
Journal:  Cancer       Date:  1989-08-01       Impact factor: 6.860

5.  Immunologic differences in human isoferritins: implications for immunologic quantitation of serum ferritin.

Authors:  J T Hazard; M Yokota; P Arosio; J W Drysdale
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

6.  Isolation of ferritin from human mammary and pancreatic carcinomas by means of antibody immunoadsorbents.

Authors:  D M Marcus; N Zinberg
Journal:  Arch Biochem Biophys       Date:  1974-06       Impact factor: 4.013

7.  Tissue ferritin concentration and prognosis in carcinoma of the breast.

Authors:  R E Weinstein; B H Bond; B K Silberberg; C B Vaughn; P Subbaiah; D R Pieper
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

8.  Characterization of ferritin from human placenta. Implications for analysis of tissue specificity and microheterogeneity of ferritins.

Authors:  D J Lavoie; D M Marcus; S Otsuka; I Listowsky
Journal:  Biochim Biophys Acta       Date:  1979-08-28

9.  Determination of placental ferritin-positive peripheral lymphocytes in early stages of breast cancer.

Authors:  H R Rosen; M Stierer; J Göttlicher; H Wolf; H Spoula; M Eibl
Journal:  Am J Surg       Date:  1993-02       Impact factor: 2.565

10.  Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.

Authors:  P Whitford; E A Mallon; W D George; A M Campbell
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more
  3 in total

1.  Immunosuppression by breast cancer associated p43-effect of immunomodulators.

Authors:  H R Rosen; C Ausch; G Reiner; M Reinerova; J Svec; H Tüchler; R Schiessel; C Moroz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Antibodies to placental immunoregulatory ferritin with transfer of polyclonal lymphocytes arrest MCF-7 human breast cancer growth in a nude mouse model.

Authors:  Marisa Halpern; Muayad A Zahalka; Leonid Traub; Chaya Moroz
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

3.  Identification of women with early breast cancer by analysis of p43-positive lymphocytes.

Authors:  L Auerbach; M Hellan; M Stierer; A C Rosen; C Ausch; R Obwegeser; E Kubista; G Wolf; H R Rosen; S Panzer
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.